Evaluation of generalization ability for deep learning-based auto-segmentation accuracy in limited field of view CBCT of male pelvic region.


Journal

Journal of applied clinical medical physics
ISSN: 1526-9914
Titre abrégé: J Appl Clin Med Phys
Pays: United States
ID NLM: 101089176

Informations de publication

Date de publication:
May 2023
Historique:
revised: 09 01 2023
received: 08 09 2022
accepted: 10 01 2023
medline: 8 5 2023
pubmed: 21 1 2023
entrez: 20 1 2023
Statut: ppublish

Résumé

The aim of this study was to evaluate generalization ability of segmentation accuracy for limited FOV CBCT in the male pelvic region using a full-image CNN. Auto-segmentation accuracy was evaluated using various datasets with different intensity distributions and FOV sizes. A total of 171 CBCT datasets from patients with prostate cancer were enrolled. There were 151, 10, and 10 CBCT datasets acquired from Vero4DRT, TrueBeam STx, and Clinac-iX, respectively. The FOV for Vero4DRT, TrueBeam STx, and Clinac-iX was 20, 26, and 25 cm, respectively. The ROIs, including the bladder, prostate, rectum, and seminal vesicles, were manually delineated. The U The mean scores ± standard deviation of visual evaluation for bladder, prostate, rectum, and seminal vesicle in all treatment machines were 1.0 ± 0.7, 1.5 ± 0.6, 1.4 ± 0.6, and 2.1 ± 0.8 points, respectively. The median DSC values for all imaging devices were ≥0.94 for the bladder, 0.84-0.87 for the prostate and rectum, and 0.48-0.69 for the seminal vesicles. Although the DSC values for the bladder and seminal vesicles were significantly different among the three imaging devices, the DSC value of the bladder changed by less than 1% point. The median MSD values for all imaging devices were ≤1.2 mm for the bladder and 1.4-2.2 mm for the prostate, rectum, and seminal vesicles. The MSD values for the seminal vesicles were significantly different between the three imaging devices. The proposed method is effective for testing datasets with different intensity distributions and FOV from training datasets.

Identifiants

pubmed: 36659871
doi: 10.1002/acm2.13912
pmc: PMC10161011
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

e13912

Subventions

Organisme : the JSPS KAKENHI
ID : 22K15804
Organisme : the JSPS KAKENHI
ID : 22H03021
Organisme : the JSPS KAKENHI
ID : 22H03022
Organisme : the JSPS KAKENHI
ID : JP22K15804
Organisme : Scientific Research B
ID : JP22H03021
Organisme : Scientific Research B
ID : JP22H03022

Informations de copyright

© 2023 The Authors. Journal of Applied Clinical Medical Physics published by Wiley Periodicals, LLC on behalf of The American Association of Physicists in Medicine.

Références

Med Phys. 2011 Apr;38(4):2088-94
pubmed: 21626941
Med Phys. 2017 Jul;44(7):e43-e76
pubmed: 28376237
Med Phys. 2013 Feb;40(2):021722
pubmed: 23387745
Comput Biol Med. 2021 Apr;131:104269
pubmed: 33639352
Bone Marrow Transplant. 2013 Mar;48(3):452-8
pubmed: 23208313
Br J Radiol. 2017 Feb;90(1070):20160059
pubmed: 27925472
J Appl Clin Med Phys. 2021 Nov;22(11):115-125
pubmed: 34643320
Radiat Oncol. 2021 Jul 22;16(1):135
pubmed: 34294090
J Appl Clin Med Phys. 2023 May;24(5):e13912
pubmed: 36659871
Radiat Oncol. 2013 Jun 26;8:154
pubmed: 23803232
Radiother Oncol. 2020 Apr;145:1-6
pubmed: 31869676
Med Image Anal. 2019 May;54:280-296
pubmed: 30959445
Phys Med. 2020 Jan;69:184-191
pubmed: 31918371
Acta Oncol. 2011 Aug;50(6):918-25
pubmed: 21767192
Med Phys. 2022 Mar;49(3):1660-1672
pubmed: 35061244
Int J Radiat Oncol Biol Phys. 2016 Mar 15;94(4):850-7
pubmed: 26972658
Med Phys. 2021 Nov;48(11):7089-7098
pubmed: 34554587
Phys Med. 2019 Aug;64:182-187
pubmed: 31515018
Med Phys. 2020 Aug;47(8):3415-3422
pubmed: 32323330
Med Image Anal. 2021 Jan;67:101829
pubmed: 33129146
Semin Radiat Oncol. 2019 Jul;29(3):185-197
pubmed: 31027636
Radiother Oncol. 2011 Feb;98(2):154-61
pubmed: 21176984
Med Phys. 2021 Nov;48(11):7112-7126
pubmed: 34636429

Auteurs

Hideaki Hirashima (H)

Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan.

Mitsuhiro Nakamura (M)

Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan.
Department of Advanced Medical Physics, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan.

Keiho Imanishi (K)

e-Growth Co., Ltd., Kyoto-shi, Kyoto, Japan.

Megumi Nakao (M)

Department of Advanced Medical Engineering and Intelligence, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan.

Takashi Mizowaki (T)

Department of Radiation Oncology and Image-Applied Therapy, Graduate School of Medicine, Kyoto University, Sakyo-ku, Kyoto, Japan.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH